✦ LIBER ✦

Bisphosphonates in multiple myeloma

✍ Scribed by John A. Kanis; Eugene V. McCloskey

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 277 KB
Volume: 88
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20000615)88:12+<3022::aid-cncr19>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ James R. Berenson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

bone destruction resulting in osteolytic lesions, osteoporosis, and pathologic frac-West Los Angeles Veterans Affairs Medical Centures in most patients as well as hypercalcemia and spinal cord compression in ter and the Jonsson Comprehensive Cancer many individuals. These patients frequently require

Bisphosphonates may potentiate effects o

Bisphosphonates may potentiate effects of thalidomide–dexamethasone combination in advanced multiple myeloma

✍ A. Ugur Ural; Ferit Avcu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

Pseudohyperphosphatemia in multiple myel

Pseudohyperphosphatemia in multiple myeloma

✍ Mavrikakis, Myron; Vaiopoulos, George; Athanassiades, Peter; Antoniades, Leto; P 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

Multiple myeloma in cosmetologists

✍ Sylvana Guidotti; William E. Wright; Dr. John M. Peters 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Hyperammonemic encephalopathy in multipl

Hyperammonemic encephalopathy in multiple myeloma

✍ Keller, Dean R.; Keller, Kathryn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

lymph node involvement with rt ureter compression that required a stent insertion. Brain CT showed a suprasellar lesion involving the diencephalic and chiasmatic regions (Fig. 1a). The patient was treated with CdA (2 hr-infusion of 0.14 mg/kg die × 7 days) and Dexamethasone (0.3 mg/kg die × 4 days).

Serum aldolase in multiple myeloma

✍ Bernard A. Sachs; George Ross; Austra Pusplatais 📂 Article 📅 1958 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB